National Research Corporation NRC Q1 2026 Earnings EPS of 021 Reported Stock Edges Higher Amid Limited Disclosures TRMB Q1 2026 Earnings EPS Beats Estimates by 794 as Stock Edges Higher AVAV Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Strategic Outlook Bolt Biotherapeutics Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage DOYU Q4 2025 Earnings Massive EPS Surprise as Company Returns to Profitability C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage